Twist Exome 2.0, the new exome panel from Twist Bioscience offers comprehensive coverage of protein-coding and noncoding regions of the genome. Image courtesy of Twist Bioscience.

The panel includes coverage of the genes responsible for rare diseases, inherited disorders, and germline cancers in humans. In addition, it features comprehensive coverage of protein-coding and noncoding regions of the genome.

Twist Bioscience, Broad Institute partner
Twist Bioscience and the Broad Institute have created a custom next-generation sequencing target enrichment exome panel to be used to research cancer...

Twist, Centogene to develop rare disease assay kits
Twist Bioscience and Centogene have signed a contract to collaborate on the development and commercialization of custom assay kits for rare diseases.

Twist Bioscience expands Alliance Panel
Twist Bioscience has expanded its Alliance Panel offering to include products designed by expert collaborators that have a wide range of clinical applications.

Twist, DeepCDR collaborate on antibody libraries
Twist Bioscience announced it is collaborating with DeepCDR to apply deep-learning algorithms to Twist's antibody discovery and optimization capabilities.